Related references
Note: Only part of the references are listed.Advances in male contraception
Stephanie T. Page et al.
ENDOCRINE REVIEWS (2008)
Efficacy and safety of incretin therapy in type 2 diabetes - Systematic review and meta-analysis
Renee E. Amori et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The role of endocannabinoid system blockade in the treatment of the metabolic syndrome
Anna I. Kakafika et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus
Priscilla Hollander
AMERICAN JOURNAL OF MEDICINE (2007)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Steven E. Kahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
Andre J. Scheen et al.
LANCET (2006)
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes
M Gary-Bobo et al.
MOLECULAR PHARMACOLOGY (2006)
Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies
R Huxley et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance
O Jbilo et al.
FASEB JOURNAL (2005)
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
D Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob mice
YL Liu et al.
INTERNATIONAL JOURNAL OF OBESITY (2005)
Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus - A meta-analysis
SL Norris et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
The evolving diabetes burden in the United States
MM Engelgau et al.
ANNALS OF INTERNAL MEDICINE (2004)
Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots
A Misra et al.
NUTRITION (2003)
The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells
M Bensaid et al.
MOLECULAR PHARMACOLOGY (2003)
Pharmacologic therapy for type 2 diabetes mellitus
RA DeFronzo
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
